AGP Picks
View all

World Tech News Turkmenistan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Tech News Turkmenistan.

Press releases published on August 5, 2026

Military Demand to Anchor Global sUAS Market Growth as Commercial Drone Adoption Expands Across Key Verticals
Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
Autonomize AI Launches Fraud, Waste, and Abuse AI-native App in the ServiceNow Store
Talos Integrates with STS Digital to Bring Institutional Crypto Options and Spot Liquidity to its Provider Network
ImageneBio Reports Second Quarter 2026 Financial Results
Rocket Doctor AI joins the B2i Digital Featured Company Program and its Network of more than 1.7 million Retail and Institutional Market Participants
UroGen Reports $50.4 Million of ZUSDURI Revenue and Provides Second Quarter 2026 Financial Results and Highlights
Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis
One Stop Systems Reports Q2 2026 Results
Altimmune to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026
Rezolve Ai’s 550 Specialist India Operations Become its Global Engine for Agentic AI
Jupiter Neurosciences, Inc. Announces Reverse Stock Split
Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes
Kura Oncology to Report Second Quarter Financial Results
CervoMed to Participate in Fireside Chat to Highlight Recent Progress in the Neflamapimod Clinical Development Program at the Canaccord Genuity 46th Annual Growth Conference
BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer
Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates
Bioventus Reports Second Quarter Financial Results
Kane Biotech Announces Engagement of DNA Advisors
Applied Biologics Receives Central IRB Approval for Phase 3 BIOxHEAL™ Clinical Trial

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

World Tech News Turkmenistan

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.